设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编兼编辑部主任:
杨秋

邮发代号:80-528
定价:20.00元
全年:240.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2018 年第 3 期 第 13 卷

特布他林与丙酸倍氯米松联合雾化吸入治疗哮喘急性发作期患者的临床效果

Clinical effect of terbutaline combined with beclomethasone dipropionate inhalation on acute attack of asthma

作者:周晓谢永伟

英文作者:

单位:350025南京军区福州总医院呼吸内科(周晓),胸外科(谢永伟)

英文单位:

关键词:

英文关键词:

  • 摘要:
  • 目的    探讨特布他林与丙酸倍氯米松联合雾化治疗哮喘急性发作期患者的临床效果。方法    选择2014年9月至2016年6月南京军区福州总医院收治的180例哮喘急性发作期的患者,按照随机数字表法分为A、B、C 3组,各60例。A组采用特布他林雾化吸入治疗,B组采用丙酸倍氯米松雾化吸入治疗,C组采用特布他林联合丙酸倍氯米松雾化吸入治疗。观察3组患者临床总有效率、症状及体征消失时间、住院时间以及不良反应发生情况。结果    C组总有效率明显高于A组和B组[93.3%(56/60)比80.0%(48/60)、76.7%(46/60)],差异均有统计学意义(均P<0.05),A组和B组总有效率差异无统计学意义(P>0.05)。治疗后,C组呼吸困难消失时间、咳嗽消失时间、肺部体征消失时间以及住院时间明显短于A组和B组,差异均有统计学意义(均P<0.05)。治疗后C组呼吸流量峰值明显高于A组和B组[(235±25)%比(219±20)%、(221±21)%],差异均有统计学意义(均P<0.05)。结论    特布他林联合丙酸倍氯米松雾化吸入治疗哮喘急性发作期效果明显,安全性高。

  • Objective    To investigate the clinical effect of terbutaline combined with beclomethasone dipropionate inhalation on acute attack of asthma. Methods    A total of 180 patients with acute exacerbation of asthma who were admitted from September 2014 to June 2016 at Fuzhou General Hospital of Nanjing Military Command of People′s Liberation Army were randomly divided into group A, B, C, with 60 cases in each group. The group A was treated by terbutaline inhalation; the group B was treated by beclomethasone dipropionate inhalation; the group C was treated by terbutaline combined with beclomethasone dipropionate inhalation. Clinical efficiency, disappear time of symptoms and signs, hospital stay time and adverse reaction rate were analyzed. Results    The total effective rate in group C was significantly higher than that in group A and B[93.3%(56/60) vs 80.0%(48/60), 76.7%(46/60)](P<0.05); the effective rate showed no significant difference between group A and B(P>0.05). After treatment, dyspnea disappear time, cough disappear time, pulmonary sign disappear time and hospital stay time in group C were significantly shorter than those in group A and B(P<0.05). The peak expiratory flow after treatment in group C was significantly higher than that in group A and B[(235±25)% vs (219±20)%, (221±21)%](P<0.05). Conclusion    Terbutaline combined with beclomethasone dipropionate inhalation is safe and effective in treatment of acute asthma attack.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:010-60213898
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭